Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment

Purpose: Exploring and studying the novel target of hepatocellular carcinoma (HCC) has been extremely important for its treatment. The principal objective of this project is to investigate whether myeloid derived growth factor (MYDGF) could accelerate the progression of HCC, and how it works. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Mao, Jie, Zhou, Tao, Chen, Xingyi, Tu, Haoyang, Ma, Jinyan, Li, Yixuan, Ding, Yushi, Yang, Yong, Wu, Hongxi, Tang, Xinying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681097/
https://www.ncbi.nlm.nih.gov/pubmed/33391471
http://dx.doi.org/10.7150/thno.49327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681097/
https://www.ncbi.nlm.nih.gov/pubmed/33391471
http://dx.doi.org/10.7150/thno.49327

Ejemplares similares